Data / Drug companies / Midodrine hydrochloride
Midodrine hydrochloride: 34 companies and 109 products in the FDA NDC directory
Midodrine hydrochloride is listed in the FDA National Drug Code Directory by 34 companies, with 109 products in commercial distribution. 109 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, and the newest product started marketing on September 1, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 34
- Products
- 109
- Generic (ANDA) products
- 109 (100.0%)
- Application numbers
- 12
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list midodrine hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bryant Ranch Prepack | 7 | tablet | Generic drugs (ANDA) | October 15, 2020 |
| Major Pharmaceuticals | 6 | tablet | Generic drugs (ANDA) | September 1, 2026 |
| NorthStar RxLLC | 6 | tablet | Generic drugs (ANDA) | June 15, 2026 |
| Bryant Ranch Prepack | 4 | tablet | Generic drugs (ANDA) | August 10, 2020 |
| Bryant Ranch Prepack | 4 | tablet | Generic drugs (ANDA) | October 15, 2020 |
| Cardinal Health 107, LLC | 4 | tablet | Generic drugs (ANDA) | September 12, 2006 |
| Advagen Pharma Ltd | 3 | tablet | Generic drugs (ANDA) | August 19, 2019 |
| Alembic Pharmaceuticals Inc. | 3 | tablet | Generic drugs (ANDA) | January 22, 2021 |
| Alembic Pharmaceuticals Limited | 3 | tablet | Generic drugs (ANDA) | January 22, 2021 |
| American Health Packaging | 3 | tablet | Generic drugs (ANDA) | June 6, 2019 |
| Apotex Corp. | 3 | tablet | Generic drugs (ANDA) | September 12, 2006 |
| Aurobindo Pharma Limited | 3 | tablet | Generic drugs (ANDA) | August 10, 2020 |
| AvKARE | 3 | tablet | Generic drugs (ANDA) | May 5, 2017 |
| AvPAK | 3 | tablet | Generic drugs (ANDA) | August 26, 2019 |
| First Nation Group, LLC | 3 | tablet | Generic drugs (ANDA) | August 13, 2025 |
| Golden State Medical Supply, Inc. | 3 | tablet | Generic drugs (ANDA) | October 1, 2020 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 3 | tablet | Generic drugs (ANDA) | March 25, 2026 |
| Lifestar Pharma LLC | 3 | tablet | Generic drugs (ANDA) | November 1, 2023 |
| Mylan Pharmaceuticals Inc. | 3 | tablet | Generic drugs (ANDA) | September 11, 2003 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 3 | tablet | Generic drugs (ANDA) | August 10, 2020 |
| Novugen Pharma (USA) LLC | 3 | tablet | Generic drugs (ANDA) | October 18, 2023 |
| PD-Rx Pharmaceuticals, Inc. | 3 | tablet | Generic drugs (ANDA) | August 19, 2019 |
| Par Health USA, LLC | 3 | tablet | Generic drugs (ANDA) | October 29, 2018 |
| Proficient Rx LP | 3 | tablet | Generic drugs (ANDA) | October 15, 2020 |
| Rising Pharma Holdings, Inc. | 3 | tablet | Generic drugs (ANDA) | April 1, 2019 |
| TruPharma, LLC | 3 | tablet | Generic drugs (ANDA) | August 19, 2019 |
| Umasuto, LLC | 3 | tablet | Generic drugs (ANDA) | March 5, 2025 |
| Upsher-Smith Laboratories, LLC | 3 | tablet | Generic drugs (ANDA) | November 3, 2004 |
| Xiromed, LLC | 3 | tablet | Generic drugs (ANDA) | October 15, 2020 |
| Zydus Lifesciences Limited | 3 | tablet | Generic drugs (ANDA) | September 17, 2020 |
| Zydus Pharmaceuticals USA Inc. | 3 | tablet | Generic drugs (ANDA) | September 17, 2020 |
| Coupler LLC | 1 | tablet | Generic drugs (ANDA) | February 1, 2025 |
| Mylan Institutional Inc. | 1 | tablet | Generic drugs (ANDA) | September 11, 2006 |
| Safecor Health, LLC | 1 | tablet | Generic drugs (ANDA) | March 13, 2026 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 109 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 109 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| alpha-Adrenergic Agonist | 109 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.